These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 8292721

  • 1. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P, Morini M, Agnelli G, Ascani A, Nenci GG.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis.
    Weitz JI, Kuint J, Leslie B, Hirsh J.
    Thromb Haemost; 1991 May 06; 65(5):541-4. PubMed ID: 1651568
    [Abstract] [Full Text] [Related]

  • 4. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar 06; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 5. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1991 Nov 01; 66(5):592-7. PubMed ID: 1839474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibrin clots obtained from plasma containing heparin show a higher sensitivity to t-PA-induced lysis.
    Nenci GG, Parise P, Morini M, Rossini A, Agnelli G.
    Blood Coagul Fibrinolysis; 1992 Jun 01; 3(3):279-85. PubMed ID: 1643205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M, Lijnen HR, Keber D, Collen D.
    Thromb Haemost; 1989 Dec 29; 62(4):1083-7. PubMed ID: 2515603
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec 29; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 13. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
    Varin R, Mirshahi S, Mirshahi P, Kierzek G, Sebaoun D, Mishal Z, Vannier JP, Yvonne Borg J, Simoneau G, Soria C, Soria J.
    Thromb Haemost; 2007 Jan 29; 97(1):27-31. PubMed ID: 17200767
    [Abstract] [Full Text] [Related]

  • 14. Influence of homocysteine on fibrin network lysis.
    Lauricella AM, Quintana I, Castañon M, Sassetti B, Kordich L.
    Blood Coagul Fibrinolysis; 2006 Apr 29; 17(3):181-6. PubMed ID: 16575255
    [Abstract] [Full Text] [Related]

  • 15. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 29; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ, Meunier AM.
    Thromb Haemost; 1990 Nov 30; 64(3):455-63. PubMed ID: 2128976
    [Abstract] [Full Text] [Related]

  • 18. The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.
    Lai BF, Zou Y, Brooks DE, Kizhakkedathu JN.
    Biomaterials; 2010 Aug 30; 31(22):5749-58. PubMed ID: 20435346
    [Abstract] [Full Text] [Related]

  • 19. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR, Gardell SJ.
    Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162
    [Abstract] [Full Text] [Related]

  • 20. Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro.
    Brass O, Belleville J, Sabattier V, Corot C.
    Blood Coagul Fibrinolysis; 1993 Oct 03; 4(5):689-97. PubMed ID: 8292718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.